A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)

202264 citationsJournal Articlegold Open Access

Authors

The CONNECT-FX trial is registered on Clinicaltrials.gov (NCT03614663).

Reduced inequalities

Published in: Journal of Neurodevelopmental Disorders

Volume 14, Issue 1, pp. 56-56

Field-Weighted Citation Impact: 10.46